Showing results (391-400 of 588) with videos related to
Sort By:
Pageof 59
Cancer Research|October 15, 2009
Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokersLynette M Sholl, Beow Y Yeap, A John Iafrate, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 8, 2008
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancerMichelangelo Fiorentino, Giorgia Zadra, Emanuele Palescandolo, et al.Genes & Development|March 21, 2013
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patientsEsther Baena, Zhen Shao, Douglas E Linn, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular SubtypesXiaoshuang Feng, Cindy Ke Zhou, Clary B Clish, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.Molecular Cancer Research : MCR|November 10, 2020
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and SerumKathryn L Penney, Svitlana Tyekucheva, Jacob Rosenthal, et al.Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survivalPaul L Nguyen, Jing Ma, Jorge E Chavarro, et al.Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG StatusKonrad H Stopsack, Amparo G Gonzalez-Feliciano, Samuel F Peisch, et al.Pageof 59